substance use disorder. Opioid related disorders
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: Participants will receive daily calci-herb supplements. Intervention 2: Control group: Participants will receive two placebo capsules daily.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Having opioid use disorder in the acute withdrawal phase Age between 18 and 70 years Providing written informed consent Willingness to participate in the study and continue follow-up until completion
Exclusion criteria
Exclusion criteria: Presence of serious and chronic diseases Severe mental disorders Inability to comply with the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Severity. Timepoint: At the beginning of the study (before the intervention) and 7, 141 days after starting Calciherb. Method of measurement: Visual pain scale.;Clinical Opiate Withdrawal Severity. Timepoint: At the beginning of the study (before the intervention) and 7, 141 days after starting Calciherb. Method of measurement: Clinical Opiate Withdrawal Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hamdollah Mosavat
Shiraz University of Medical Sciences
Outcome results
None listed